Analysis of European Biotech Companies on the Stock Markets
The BIOCOM report “Analysis of European Biotech Companies on the Stock Markets: US vs Europe” provides a complete overview of the current European public biotech sector. Ever since 2012, it covers all IPOs, follow-on financings, and secondary listings on all major stock market centres in Europe, as well as on Nasdaq.
Do you want to know more? Are you ready to become part of the European biotech picture? Contact us now:
Due to its broad spectrum of investors, the US Nasdaq continues to be an attractive stock market for European...
An IPO is a veritable option for funding biotech companies. This has been proven by the successful listing of...